These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 36923222)

  • 1. New insights into the inter-organ crosstalk mediated by ChREBP.
    Carbinatti T; Régnier M; Parlati L; Benhamed F; Postic C
    Front Endocrinol (Lausanne); 2023; 14():1095440. PubMed ID: 36923222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism.
    Fisher FM; Kim M; Doridot L; Cunniff JC; Parker TS; Levine DM; Hellerstein MK; Hudgins LC; Maratos-Flier E; Herman MA
    Mol Metab; 2017 Jan; 6(1):14-21. PubMed ID: 28123933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of ChREBP in carbohydrate sensing and NAFLD development.
    Régnier M; Carbinatti T; Parlati L; Benhamed F; Postic C
    Nat Rev Endocrinol; 2023 Jun; 19(6):336-349. PubMed ID: 37055547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.
    Lei Y; Hoogerland JA; Bloks VW; Bos T; Bleeker A; Wolters H; Wolters JC; Hijmans BS; van Dijk TH; Thomas R; van Weeghel M; Mithieux G; Houtkooper RH; de Bruin A; Rajas F; Kuipers F; Oosterveer MH
    Hepatology; 2020 Nov; 72(5):1638-1653. PubMed ID: 32083759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Roles of Carbohydrate Response Element Binding Protein in the Relationship between Carbohydrate Intake and Diseases.
    Iizuka K
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
    Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C
    J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary carbohydrate and control of hepatic gene expression: mechanistic links from ATP and phosphate ester homeostasis to the carbohydrate-response element-binding protein.
    Agius L
    Proc Nutr Soc; 2016 Feb; 75(1):10-18. PubMed ID: 26264689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-Sensing Transcription Factor MondoA/ChREBP as Targets for Type 2 Diabetes: Opportunities and Challenges.
    Song Z; Yang H; Zhou L; Yang F
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31623194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ChREBP, a glucose-responsive transcriptional factor, enhances glucose metabolism to support biosynthesis in human cytomegalovirus-infected cells.
    Yu Y; Maguire TG; Alwine JC
    Proc Natl Acad Sci U S A; 2014 Feb; 111(5):1951-6. PubMed ID: 24449882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transcription factor ChREBP – the coordinator of carbohydrate and lipid metabolism].
    Krawczak J; Owczarek A; Winiarska K
    Postepy Biochem; 2020 Mar; 66(1):30-37. PubMed ID: 33320482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism.
    Kim TH; Hong DG; Yang YM
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with myo-inositol attenuates binding of the carbohydrate-responsive element-binding protein to the ChREBP-β and FASN genes in rat nonalcoholic fatty liver induced by high-fructose diet.
    Shimada M; Ichigo Y; Shirouchi B; Takashima S; Inagaki M; Nakagawa T; Hayakawa T
    Nutr Res; 2019 Apr; 64():49-55. PubMed ID: 30802722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causative and Sanative dynamicity of ChREBP in Hepato-Metabolic disorders.
    Daniel PV; Mondal P
    Eur J Cell Biol; 2020 Nov; 99(8):151128. PubMed ID: 33232883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome.
    Iizuka K; Horikawa Y
    Endocr J; 2008 Aug; 55(4):617-24. PubMed ID: 18490833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced Nogo expression inhibits diet-induced metabolic disorders by regulating ChREBP and insulin activity.
    Zhang S; Guo F; Yu M; Yang X; Yao Z; Li Q; Wei Z; Feng K; Zeng P; Zhao D; Li X; Zhu Y; Miao QR; Iwakiri Y; Chen Y; Han J; Duan Y
    J Hepatol; 2020 Dec; 73(6):1482-1495. PubMed ID: 32738448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Carbohydrate Response Element Binding Protein in Intestinal and Hepatic Fructose Metabolism.
    Iizuka K
    Nutrients; 2017 Feb; 9(2):. PubMed ID: 28241431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The absence of hepatic glucose-6 phosphatase/ChREBP couple is incompatible with survival in mice.
    Rajas F; Dentin R; Cannella Miliano A; Silva M; Raffin M; Levavasseur F; Gautier-Stein A; Postic C; Mithieux G
    Mol Metab; 2021 Jan; 43():101108. PubMed ID: 33137488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone modifications in fatty acid synthase modulated by carbohydrate responsive element binding protein are associated with non‑alcoholic fatty liver disease.
    Cai C; Yu H; Huang G; Du X; Yu X; Zhou Y; Shen W
    Int J Mol Med; 2018 Sep; 42(3):1215-1228. PubMed ID: 29786745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HGFAC is a ChREBP-regulated hepatokine that enhances glucose and lipid homeostasis.
    Sargsyan A; Doridot L; Hannou SA; Tong W; Srinivasan H; Ivison R; Monn R; Kou HH; Haldeman JM; Arlotto M; White PJ; Grimsrud PA; Astapova I; Tsai LT; Herman MA
    JCI Insight; 2023 Jan; 8(1):. PubMed ID: 36413406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of Liver and Pancreatic Islet Crosstalk to β-Cell Function/Dysfunction in the Presence of Fatty Liver.
    López-Bermudo L; Luque-Sierra A; Maya-Miles D; Gallego-Durán R; Ampuero J; Romero-Gómez M; Berná G; Martín F
    Front Endocrinol (Lausanne); 2022; 13():892672. PubMed ID: 35651973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.